Buffered drug formulations for transdermal electrotransport...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/42 (2006.01) A61K 47/18 (2006.01) A61K 47/22 (2006.01) A61N 1/30 (2006.01) A61P 3/10 (2006.01) A61P 29/00 (2006.01) A61K 9/70 (2006.01) A61K 38/08 (2006.01) A61K 38/27 (2006.01)

Patent

CA 2309818

Buffered drug formulations for transdermal electrotransport delivery are disclosed. The formulations utilize a dipeptide as a buffer and allow for more efficient electrotransport delivery of drugs, e.g., polypetide drugs, via the transdermal route.

L'invention concerne des formulations pharmaceutiques tamponnées destinées à être administrées par électrotransport transdermique. Ces formulations, qui utilisent un dipeptide comme tampon, permettent une administration par électrotransport plus efficace des médicaments, notamment de médicaments polypeptidiques, par voie transdermique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Buffered drug formulations for transdermal electrotransport... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Buffered drug formulations for transdermal electrotransport..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Buffered drug formulations for transdermal electrotransport... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1659024

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.